BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34769614)

  • 21. Impact of overweight on chronic microvascular complications in type 1 diabetic patients.
    De Block CE; De Leeuw IH; Van Gaal LF
    Diabetes Care; 2005 Jul; 28(7):1649-55. PubMed ID: 15983315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clustering of microvascular complications in Type 1 diabetes mellitus.
    Bjerg L; Hulman A; Charles M; Jørgensen ME; Witte DR
    J Diabetes Complications; 2018 Apr; 32(4):393-399. PubMed ID: 29478814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.
    Dyck PJ; Kratz KM; Karnes JL; Litchy WJ; Klein R; Pach JM; Wilson DM; O'Brien PC; Melton LJ; Service FJ
    Neurology; 1993 Apr; 43(4):817-24. PubMed ID: 8469345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes.
    Kim ES; Lee SW; Mo EY; Moon SD; Han JH
    Endocrine; 2015 Nov; 50(2):405-12. PubMed ID: 25846483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran.
    Kiani J; Moghimbeigi A; Azizkhani H; Kosarifard S
    Arch Iran Med; 2013 Jan; 16(1):17-9. PubMed ID: 23273229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing severity of cardiac autonomic neuropathy is associated with increasing prevalence of nephropathy, retinopathy, and peripheral neuropathy in Turkish type 2 diabetics.
    Bilal N; Erdogan M; Ozbek M; Cetinkalp S; Karadeniz M; Ozgen AG; Saygili F; Yilmaz C; Tüzün M; Kabalak T
    J Diabetes Complications; 2008; 22(3):181-5. PubMed ID: 18413163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.
    Zander E; Seidlein I; Herfurth S; Heinke P; Chlup R; Badendick K; Strese J; Zander G; Schulz B
    Exp Clin Endocrinol; 1992; 99(2):102-7. PubMed ID: 1639116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes-related chronic complications in Brazilian adolescents with type 1 diabetes. A multicenter cross-sectional study.
    Gomes MB; Calliari LE; Conte D; Correa CL; Drummond KRG; Mallmann F; Pinheiro AA; Muniz LH; Leal FSL; Morales PH; Negrato CA
    Diabetes Res Clin Pract; 2021 Jul; 177():108895. PubMed ID: 34090967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates.
    Tommerdahl KL; Shapiro ALB; Nehus EJ; Bjornstad P
    Pediatr Nephrol; 2022 Jan; 37(1):79-93. PubMed ID: 33852054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of differing dietary, metabolic, and clinical risk factors with microvascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. II.
    Paisey RB; Arredondo G; Villalobos A; Lozano O; Guevara L; Kelly S
    Diabetes Care; 1984; 7(5):428-33. PubMed ID: 6499636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity and Diabetic Complications: A Study from the Nationwide Diabetes Report of the National Program for Prevention and Control of Diabetes (NPPCD-2021) Implications for Action on Multiple Scales.
    Moosaie F; Ghaemi F; Mechanick JI; Shadnoush M; Firouzabadi FD; Kermanchi J; Poopak A; Esteghamati S; Forouzanfar R; Abhari SMF; Mansournia MA; Khosravi A; Gholami E; Nakhjavani M; Esteghamati A
    Prim Care Diabetes; 2022 Jun; 16(3):422-429. PubMed ID: 35396199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between diabetes self-management and microvascular complications in patients with type 2 diabetes.
    Mehravar F; Mansournia MA; Holakouie-Naieni K; Nasli-Esfahani E; Mansournia N; Almasi-Hashiani A
    Epidemiol Health; 2016; 38():e2016004. PubMed ID: 26883737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microvascular Complications of Type 2 Diabetes Mellitus.
    Faselis C; Katsimardou A; Imprialos K; Deligkaris P; Kallistratos M; Dimitriadis K
    Curr Vasc Pharmacol; 2020; 18(2):117-124. PubMed ID: 31057114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular autonomic neuropathy, autonomic symptoms and diabetic complications in 674 type 2 diabetes.
    Chen HT; Lin HD; Won JG; Lee CH; Wu SC; Lin JD; Juan LY; Ho LT; Tang KT
    Diabetes Res Clin Pract; 2008 Nov; 82(2):282-90. PubMed ID: 18824270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center.
    Porter M; Channa R; Wagner J; Prichett L; Liu TYA; Wolf RM
    Pediatr Diabetes; 2020 Aug; 21(5):856-862. PubMed ID: 32410329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes.
    Monti MC; Lonsdale JT; Montomoli C; Montross R; Schlag E; Greenberg DA
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4650-5. PubMed ID: 17878250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications.
    Ayad F; Belhadj M; Pariés J; Attali JR; Valensi P
    Diabet Med; 2010 Jul; 27(7):804-11. PubMed ID: 20636962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence of secondary complications in patients with type I diabetes mellitus. Results of a retrospective analysis of 549 type I diabetic patients of the Ulm University clinic].
    Hauner H; Schubert J; Pfeiffer EF
    Med Klin (Munich); 1990 Dec; 85(12):690-5. PubMed ID: 2087208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis.
    Hui Z; Chen YM; Gong WK; Lai JB; Yao BB; Zhao ZJ; Lu QK; Ye K; Ji LD; Xu J
    Diab Vasc Dis Res; 2022; 19(4):14791641221122918. PubMed ID: 35989592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prevalence of Diabetic Microvascular Complications in China and the USA.
    Lin YK; Gao B; Liu L; Ang L; Mizokami-Stout K; Pop-Busui R; Zhang L
    Curr Diab Rep; 2021 Apr; 21(6):16. PubMed ID: 33835284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.